Microbix Biosystems (TSE:MBX) Share Price Passes Below 200 Day Moving Average – Should You Sell?

Microbix Biosystems Inc. (TSE:MBX)’s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$0.24 and traded as low as C$0.24. Microbix Biosystems shares last traded at C$0.25, with a volume of 84,500 shares trading hands.

Microbix Biosystems Price Performance

The stock has a fifty day simple moving average of C$0.24 and a 200-day simple moving average of C$0.24. The company has a market capitalization of C$33.95 million, a PE ratio of -8.17 and a beta of 0.47. The company has a current ratio of 7.51, a quick ratio of 5.57 and a debt-to-equity ratio of 30.47.

Microbix Biosystems (TSE:MBX) last released its quarterly earnings data on Thursday, February 12th. The company reported C($0.01) EPS for the quarter. Microbix Biosystems had a negative net margin of 25.48% and a negative return on equity of 14.88%. The business had revenue of C$4.22 million during the quarter. Equities analysts anticipate that Microbix Biosystems Inc. will post 0.02 earnings per share for the current year.

About Microbix Biosystems

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.